Aspira Women's Health to Host R&D Day on January 4, 2024; Updating Ovarian Cancer Tests
Aspira Women’s Health announced it will host a virtual R&D Day on January 4, 2024, at 11:00 am ET. The event will feature experts who will present the exciting progress of the company’s product pipeline. Registration link accessible in our full report. The event will be hosted by CEO Nicole Sandford. She will be joined by Jody Berry, PhD, Chief Scientific Officer for Aspira Women’s Health, and Kevin Elias, MD, Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School, Director of Gynecologic Oncology Laboratory at Brigham and Women’s Hospital in Boston, MA, gynecologic oncologist, and surgeon-scientist at the Dana-Farber Cancer Institute. Product updates will include upcoming milestones, pending publications, and future revenue potential for: OvaWatchSM: The only commercially available ovarian cancer blood test for women diagnosed with an adnexal mass considered indeterminate or benign by clinical assessment. It will be available soon for longitudinal mass monitoring. OvaMDxTM: A promising new blood test that combines Aspira’s proprietary protein biomarker technology with miRNAs licensed from the Dana-Farber Cancer Institute. EndoCheckSM: The first protein biomarker test for the identification of ovarian endometriosis, including endometrioma. EndoMDxTM: A multimarker test that combines proteins, miRNA, and clinical partners led by the Dana-Farber Cancer Institute.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.